MedTrace Logo

Trans-rectal Focal Microwave Ablation of the Index Tumor in Patients With Low-risk Prostate Cancer

NCT03023345 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2025-09-05

No results posted yet for this study

Summary

The purpose of this study is to determine if trans-rectal microwave ablation of the index tumor of patients with low-risk prostate cancer is sufficiently precise and safe, using MRI-transrectal ultrasound image registration.

Conditions

  • Low-Risk Prostate Cancer

Interventions

DEVICE

Microwave trans rectal focal treatment

Microwave trans-rectal ablation of the prostatic index tumor using MRI-transrectal ultrasound image registration

Sponsors & Collaborators

  • Unité de Recherche Clinique Necker Cochin, Fr

    collaborator UNKNOWN

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Nicolas BARRY DELONGCHAMPS, MD, PhD · Assistance Publique - Hôpitaux de Paris

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Max Age
76 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-12
Primary Completion
2018-11-05
Completion
2019-04-23

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03023345 on ClinicalTrials.gov